Renaissance Technologies’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4K | Buy |
11,030
+1,000
| +10% | +$1.76K | ﹤0.01% | 3472 |
|
|
2025
Q1 | $13.6K | Buy |
+10,030
| New | +$13.6K | ﹤0.01% | 3377 |
|
|
2024
Q1 | – | Sell |
-6,310
| Closed | -$43K | – | 4016 |
|
|
2023
Q4 | $43K | Buy |
6,310
+500
| +9% | +$3.41K | ﹤0.01% | 3478 |
|
|
2023
Q3 | $37K | Buy |
5,810
+370
| +7% | +$2.36K | ﹤0.01% | 3443 |
|
|
2023
Q2 | $45K | Buy |
+5,440
| New | +$45K | ﹤0.01% | 3637 |
|